LATNOP, LATNOPROS, LATNOPROST, LATNOT (Neo Health (Australia) Pty Ltd)
Product name
LATNOP, LATNOPROS, LATNOPROST, LATNOT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
169 working days (255)
Active ingredients
Latanoprost
Registration type
New generic medicine
Indication
LATNOP, LATNOPROS, LATNOPROST, LATNOT (eye drops) is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.